Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP591342.RAvN9tGxrgbv--ndWKXFbRVxlnFiJbChLDGVBBSYzjsto130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP591342.RAvN9tGxrgbv--ndWKXFbRVxlnFiJbChLDGVBBSYzjsto130_assertion type Assertion NP591342.RAvN9tGxrgbv--ndWKXFbRVxlnFiJbChLDGVBBSYzjsto130_head.
- NP591342.RAvN9tGxrgbv--ndWKXFbRVxlnFiJbChLDGVBBSYzjsto130_assertion description "[Patients with lung cancer had higher serum angiopoietin-2 (2,046.3 +/- 1,171.3 pg/mL vs 1,269.8 +/- 494.1 pg/mL, p < 0.001) and VEGF (542.9 +/- 445.8 pg/mL vs 364.7 +/- 185.9 pg/mL, p < 0.05) [mean +/- SD] levels than the control group.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591342.RAvN9tGxrgbv--ndWKXFbRVxlnFiJbChLDGVBBSYzjsto130_provenance.
- NP591342.RAvN9tGxrgbv--ndWKXFbRVxlnFiJbChLDGVBBSYzjsto130_assertion evidence source_evidence_literature NP591342.RAvN9tGxrgbv--ndWKXFbRVxlnFiJbChLDGVBBSYzjsto130_provenance.
- NP591342.RAvN9tGxrgbv--ndWKXFbRVxlnFiJbChLDGVBBSYzjsto130_assertion SIO_000772 17505039 NP591342.RAvN9tGxrgbv--ndWKXFbRVxlnFiJbChLDGVBBSYzjsto130_provenance.
- NP591342.RAvN9tGxrgbv--ndWKXFbRVxlnFiJbChLDGVBBSYzjsto130_assertion wasDerivedFrom befree-20140225 NP591342.RAvN9tGxrgbv--ndWKXFbRVxlnFiJbChLDGVBBSYzjsto130_provenance.
- NP591342.RAvN9tGxrgbv--ndWKXFbRVxlnFiJbChLDGVBBSYzjsto130_assertion wasGeneratedBy ECO_0000203 NP591342.RAvN9tGxrgbv--ndWKXFbRVxlnFiJbChLDGVBBSYzjsto130_provenance.